Pharmacology Of ANS Flashcards
Cholinergic receptors types
- Nicotinic receptor
* Muscarinic receptor
Nicotinic receptor type
Ligand-gated ion channel receptor (ionotropic)
Muscarinic receptor type
G-protein coupled receptor (GPCR) (metabotropic)
Nicotinic actions
- Skeletal muscle: promote Ms contraction
- Peripheral neuronal: stimulation of autonomic ganglia, secretion of cathecholamimes by adrenal medulla
- CNS neuronal (nAChR): regulate release of neurotransmitters, function on cognition and pain perception
M1 receptor function
- Learning and memory
* GI secretion and motilty
M2 receptor function
- SA node: decrease HR, AV node: decrease conduction
* Smooth muscle: increase contraction
M3 receptor function
- smooth muscle: increased contraction (eg detrusor)
* Gastric and exocrine secretion
Muscarinic receptors G protein types
- M1, M3, M5: Gq coupled
* M2, M4: Gi coupled
Muscarinic actions on heart and blood vessels
- Heart: Bradycardia (negative chronotropy)
- Atria: Decreased contractile strength (negative intotropy)
- AV node: decrease in conduction velocity (negative dromotropy), increase in refractory period
- Blood vessels: dilatation via release of NO
Muscarinic action on eye
- Contraction of sphincter muscle (miosis)
- Contraction of ciliary muscle (near vision)
- Decreased IOP (increased aqueous humour outflow via wider angle and open trabecular meshwork as a result of miosis)
Muscarinic action on urinary bladder
- Contraction of detrusor
* Relaxation of trigone and sphincter
ACh toxicology
AChE inhibitor drugs prevent destruction of ACh -> cholinergic over-activity
ACh removal
Atropine large dose, maintained for > 72h
Sympathomimetics
Adrenoreceptor agonists that mimic effect of sympathetic stimulation
Sympatholytics
Adrenoreceptor antagonists that reduce/block sympathetic stimulation
Termination of action of catecholamines
- Reuptake into nerve terminals
- Diffusion out of junctional cleft and reuptake at extraneuronal sites
- Metabolism by 2 enzymes: COMT, MAO
2 main actions of sympathomimetic agents
- Alpha-adrenergic actions
* Beta-adrenergic actions
Alpha-adrenergic actions
Stimulatory except on gut
Beta-adrenergic actions
Inhibitory except on heart
α₁ adrenergic receptor
GPCR - coupled to Gαq
α₁ adrenergic receptor stimulatory effects
Contraction of VSM, sphincters and promote cardiac growth
α₁-selective agonists
- Phenylephrine
- PPA (nasal decongestant)
- Midodrine
α₁-selective antagonists
- Prazosin
* Doxazosin (hypertension, benign prostatic hypertrophy)
α₂ adrenergic receptors type
GPCR - coupled to Gαi and Gαo
α₂ adrenergic receptors function
Suppress sympathetic output and increase vagal tone
α₂ adrenergic agonists
- Methyldopa, guanfacine: lower BP -> hypotension (treat hypertension)
- Apraclonidine, brimonidine: decrease prod of aqueous humour, reduces IOP (treat glaucoma)